CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Takeda Pharmaceuticals U.S.A. Inc. v. Par Pharmaceutical Inc.

1:12-cv-00419

Overview

Case Number 1:12-cv-00419
Filing Date 2012-04-04
Status Terminated
Termination Date 2014-09-22
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Par Pharmaceutical Inc. Operating Company

Represented By

9 Attorneys Listed

Jaclyn C. Levy

Friedlander & Gorris, P.A.

Tel: +1 (302) 984-6000
Fax: +1 (302) 658-1192

Friedlander & Gorris, P.A., 1201 N. Market Street

Aziz Burgy

Email: aburgy@axinn.com

Katharine Lester Mowery

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7623

Richards, Layton & Finger, PA, One Rodney Square

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Janine A. Carlan

Email: janine.carlan@afslaw.com

Stephen Yang

Email: syang@steptoe.com

Crystal R. Canterbury

Email: ccanterbury@perkinscoie.com

Bradford C. Frese

Email: bradford.frese@afslaw.com

Anthony W. Shaw

Email: shaw.anthony@arentfox.com

Counter Defendant

Takeda Pharmaceuticals U.S.A., Inc. Operating Company

Represented By

4 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 8 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (8): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

12 Patents

There are 12 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7619004
Methods for concomitant administration of colchicine and macrolide antibiotics
Filed: 2008-12-03
Issued: 2009-11-17
Active (2.0 yrs remaining)
Expires: 2028-12-03
US7601758
Methods for concomitant administration of colchicine and macrolide antibiotics in the treatment of gout flares
Filed: 2009-02-10
Issued: 2009-10-13
Active (2.2 yrs remaining)
Expires: 2029-02-10
US7820681
Methods for concomitant administration of colchicine and a second active agent
Filed: 2009-02-17
Issued: 2010-10-26
Active (2.2 yrs remaining)
Expires: 2029-02-17
US7915269
Methods for concomitant administration of colchicine and a second active agent
Filed: 2010-08-18
Issued: 2011-03-29
Active (3.7 yrs remaining)
Expires: 2030-08-18
US7964647
Colchicine compositions and methods
Filed: 2009-03-20
Issued: 2011-06-21
Active (2.3 yrs remaining)
Expires: 2029-03-20

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

6

Dispositive

0

Granted

0

Denied

0

Pending / Review

3

Motions by Category

Claim Construction / Markman Filing 4 Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
Joint MOTION to Amend/Correct Second Amended Scheduling Order - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Mary W. Bourke Letter to the Hon...
Entry #77 • 2013-06-24 Document →
Procedural / Extension Motion Pending / Under Review
MOTION to Amend/Correct 1 Complaint, PLAINTIFF'S UNOPPOSED MOTION TO LEAVE TO FILE AN AMENDED COMPLAINT - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachm...
Entry #73 • 2013-06-11 Document →
Claim Construction / Markman Filing Moot / Terminated
ORDER Setting Teleconference: ( A Telephone Conference is set for 6/4/2013 at 12:00 PM before Judge Sue L. Robinson). IT IS FURTHER ORDERED that Civil Action No...
Entry #70 • 2013-05-23 Document →
Claim Construction / Markman Filing Moot / Terminated
ORDER Setting Teleconference: ( A Telephone Conference is set for 6/4/2013 at 12:00 PM before Judge Sue L. Robinson). IT IS FURTHER ORDERED that Civil Action No...
Entry #70 • 2013-05-23 Document →
Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 11/9/2012. Amended Pleadings due by 11/9/201...
Entry #32 • 2012-08-15 Document →
Claim Construction / Markman Filing Referred to Magistrate
ORDER REFERRING CASE to Magistrate Judge Mary Pat Thynge. Judge Thynge shall conduct all proceedings related to discovery disputes, alternate dispute resolution...
Entry #22 • 2012-06-20 Document →

Docket Entries

(106 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Par Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1050204.) - filed by AR Holding Company Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Civil Cover Sheet)(lih) (Entered: 04/04/2012)

Entry #1 • 2012-04-04
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (lih) (Entered: 04/04/2012)

Entry #2 • 2012-04-04
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/15/2012. Date of Expiration of Patent: 12/3/2028.Thirty Month Stay Deadline: 9/15/2014. (lih) (Entered: 04/04/2012)

Entry #3 • 2012-04-04
1

Disclosure Statement pursuant to Rule 7.1 filed by AR Holding Company Inc. identifying Corporate Parent URL Pharma Inc. for AR Holding Company Inc.. (lih) (Entered: 04/04/2012)

Entry #4 • 2012-04-04
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,619,004 B1; 7,601,758 B1; 7,820,681 B1; 7,915,269 B2; 7,964,647 B2; 7,964,648 B2; 7,981,938 B2; 8,093,296 B2; 8,093,297 B2; 8,097,655 B2. (lih) (Entered: 04/09/2012)

Entry #5 • 2012-04-04
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc